Position in VERA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$965,479
-$249,121 QoQ
Shares Held
23,999
+0.1% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VERA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GC Wealth Management RIA, LLC holds $5,541,194 across 7 Biotechnology names. VERA ranks #3 (17.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,297 | $1,774,754 | |
| 2 | CUE |
Cue Biopharma, Inc.
|
4,631,644 | $1,065,278 | |
| 3 | VERA |
Vera Therapeutics, Inc.
This page
|
23,999 | $965,479 | |
| 4 | SLNO |
Soleno Therapeutics Inc
|
20,027 | $670,503 | |
| 5 | TECH |
BIO-TECHNE Corp
|
11,084 | $579,249 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,022 | $456,363 | |
| 7 | LCTX |
Lineage Cell Therapeutics, Inc.
|
18,714 | $29,568 |
All Filings in VERA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $965,479 | 23,999 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,214,600 | 23,985 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $1,129,998 | 38,885 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $319,638 | 13,567 | Shares | Sole | 2025-07-17 | |
| No filing history on record for this holder in this stock. | ||||||